VILDAPHAGE M TABLET

Ingredients :- Vildagliptin 50 mg + Metformin 500 mg

VILDAPHAGE M TABLET – Used for managing type 2 diabetes mellitus.

Packing of 10 tablets strip

1. Indications
 - Type 2 Diabetes Mellitus: VILDAPHAGE M TABLET is indicated for the treatment of adults with type 2 diabetes mellitus, especially when diet and exercise alone fail to achieve adequate glycemic control.

 - Dual Therapy Requirement: This tablet is used when a combination of therapeutic agents is needed to control blood sugar levels, providing enhanced effectiveness over monotherapy.

 - Risk Reduction of Diabetic Complications: It is prescribed to prevent long-term complications such as neuropathy, nephropathy, and cardiovascular issues in diabetic patients.
 
2. Benefits
 - Combination Effect: VILDAPHAGE M TABLET provides the combined benefits of two complementary antidiabetic agents, helping improve glycemic control more effectively.

 - Better Glycemic Outcomes: It aids in reducing fasting blood glucose levels and postprandial sugar spikes, helping maintain a consistent glucose profile.

 - Weight-Friendly Profile: The formulation is generally weight neutral, which is beneficial for overweight or obese diabetic individuals.

 - Low Hypoglycemia Risk: When used appropriately, this medication carries a relatively low risk of causing hypoglycemia.
 
3. Dosage and Administration
 - Dosage Determination: The exact dosage is determined by a physician based on the patient’s medical history, blood glucose levels, and previous treatment response.

 - Administration: VILDAPHAGE M TABLET should be taken with meals to reduce gastrointestinal side effects and to enhance absorption and effectiveness.

 - Consistent Timing: It should be taken at the same times every day to maintain stable blood levels and ensure maximum benefit.
 
4. Mechanism of Action
 - Multi-Pronged Approach: VILDAPHAGE M TABLET works by targeting multiple pathways. One component enhances insulin secretion in response to high blood glucose levels, while the other component improves insulin sensitivity and reduces hepatic glucose production.

 - Post-Meal Glucose Control: By slowing glucose absorption and enhancing insulin response, it effectively controls blood sugar after meals.

 - Synergistic Effect: The two agents work synergistically to offer a more comprehensive approach to glucose management in type 2 diabetes.
 
5. Side Effects
 - Digestive Disturbances: Common side effects include stomach upset, bloating, and mild diarrhea, especially during the initial phase of treatment.

 - Headache and Weakness: Some individuals may experience mild headache or fatigue during treatment initiation.

 - Metallic Taste: A temporary metallic taste in the mouth is occasionally reported but usually subsides with continued use.

 - Rare Complications: In rare cases, allergic reactions or lactic acidosis (a serious but uncommon side effect) can occur, requiring immediate medical attention.
 
6. Precautions
 - Renal Monitoring: Kidney function should be evaluated before starting therapy and monitored regularly during prolonged use of VILDAPHAGE M TABLET.

 - Liver Enzyme Monitoring: Regular liver function tests may be necessary for individuals with pre-existing liver conditions.

 - Avoid Alcohol: Alcohol intake should be minimized as it can increase the risk of metabolic complications and reduce treatment effectiveness.

 - Medical Supervision: Patients undergoing surgery or radiographic procedures with contrast media may need to temporarily discontinue the medication.
 
7. Conclusion
 In conclusion, VILDAPHAGE M TABLET provides a powerful, dual-action oral therapy for individuals struggling to manage type 2 diabetes with lifestyle changes alone. Its combination approach offers better glucose control, fewer sugar fluctuations, and a relatively low risk of hypoglycemia. Adhering to the prescribed regimen, maintaining regular health check-ups, and following dietary and lifestyle modifications can maximize the benefits of this medication while minimizing potential risks.